Xinwei Han

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Yuyuan Zhang · 4 shared papers, 2022–2025 · strength 0.74
   • Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6↗
   • Paper Co-alteration of Myc and RTK-RAS pathways defines a liver-metastatic propensity and immune-cold subgroup of pancreatic … DOI 10.1016/j.gendis.2023.05.006↗
   • Paper Crosstalk between regulated cell death and immunity in redox dyshomeostasis for pancreatic cancer. DOI 10.1016/j.cellsig.2023.110774↗
2. Libo Wang · 4 shared papers, 2022–2025 · strength 0.71
   • Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6↗
   • Paper Genome-scale CRISPR-Cas9 screening stratifies pancreatic cancer with distinct outcomes and immunotherapeutic efficacy. DOI 10.1016/j.cellsig.2023.110811↗
   • Paper Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratificatio… DOI 10.1016/j.csbj.2022.02.031↗
3. Peng Luo · 2 shared papers, 2024–2025 · strength 0.43
   • Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6↗
   • Paper Co-alteration of Myc and RTK-RAS pathways defines a liver-metastatic propensity and immune-cold subgroup of pancreatic … DOI 10.1016/j.gendis.2023.05.006↗
4. Rongtao Zhu · 2 shared papers, 2022 · strength 0.30
   • Paper Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratificatio… DOI 10.1016/j.csbj.2022.02.031↗
   • Paper Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pan… DOI 10.7554/elife.80150↗
5. Weijie Wang · 2 shared papers, 2022 · strength 0.30
   • Paper Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratificatio… DOI 10.1016/j.csbj.2022.02.031↗
   • Paper Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pan… DOI 10.7554/elife.80150↗
6. Yuling Sun · 2 shared papers, 2022 · strength 0.30
   • Paper Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratificatio… DOI 10.1016/j.csbj.2022.02.031↗
   • Paper Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pan… DOI 10.7554/elife.80150↗
7. Xing Zhou · 1 shared paper, 2025 · strength 0.22
   • Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6↗
8. Jian Zhang · 1 shared paper, 2024 · strength 0.21
   • Paper Co-alteration of Myc and RTK-RAS pathways defines a liver-metastatic propensity and immune-cold subgroup of pancreatic … DOI 10.1016/j.gendis.2023.05.006↗
9. Zhaokai Zhou · 1 shared paper, 2023 · strength 0.16
   • Paper Crosstalk between regulated cell death and immunity in redox dyshomeostasis for pancreatic cancer. DOI 10.1016/j.cellsig.2023.110774↗
10. Jianguo Wen · 1 shared paper, 2023 · strength 0.16
    • Paper Crosstalk between regulated cell death and immunity in redox dyshomeostasis for pancreatic cancer. DOI 10.1016/j.cellsig.2023.110774↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.